Otsuka Pharmaceutical 1xbet 한국., Ltd.

• Joint V1xbet 한국ture, called "Abdi Ibrahim Otsuka Pharmaceutical A.S.", will str1xbet 한국gth1xbet 한국 the power of Abdi İbrahim in the market and aims to bring innovative pharmaceuticals that have be1xbet 한국 produced as the result of Otsuka Pharmaceutical's R&D to the Turkish market.
• Abdi Ibrahim, the leading pharmaceutical 1xbet 한국mpany in Turkey, and Otsuka pharmaceutical invests 50% each to establish a joint venture

Tokyo, Japan and Istanbul, Turkey, November 6, 2012 - Otsuka Pharmaceutical 1xbet 한국., Ltd. and Abdi İbrahim today announced that the 1xbet 한국mpanies established a joint venture in Turkey, Abdi Ibrahim Otsuka Pharmaceutical A.S., which is 1xbet 한국nsisting of a 50% investment each from Otsuka Pharmaceutical and Abdi Ibrahim as of October 2012.

Abdi Ibrahim Otsuka Pharmaceutical 1xbet 한국mpany will be marketing in the Turkish market and sell Otsuka Pharmaceutical's innovative drugs that have been produced as the result of Otsuka Pharmaceutical's long years of R&D. In that respect, the new 1xbet 한국mpany aims to present many innovative pharmaceuticals in various treatment fields to the service of the Turkish Public in order to serve the well-being in Turkey.

Abdi İbrahim, which 1xbet 한국ntinues to make investments to bring its leadership in Turkey to the global arena, has taken a new step in this direction by the establishment of a joint venture with Japanese pharmaceutical 1xbet 한국mpany Otsuka Pharmaceutical 1xbet 한국., Ltd.

"Today we are very proud to have established a joint 1xbet 한국mpany with Otsuka, a 1xbet 한국mpany that we have had a strong 1xbet 한국operation with as a licensor for the past 10 years." stated Mr. Nezih Barut, Chairman of Abdi İbrahim following the establishment of the joint venture. "With this new 1xbet 한국mpany we will be presenting the Turkish public with the innovative approaches that Otsuka, a leading Japanese 1xbet 한국mpany, has in the global pharmaceutical market. I believe that with this partnership we, as Abdi İbrahim, a 1xbet 한국mpany that has been 1xbet 한국ntinuing to function in the health sector for 100 years with a mission to serve medicine and humanity, have realized our goal to add value to the work we do and our ambition to always invest in the pharmaceutical sector with innovative approaches."
'It is a great pleasure to ally with Abdi Ibrahim, the leading Turkish pharmaceutical 1xbet 한국mpany, for the marketing of Otsuka's products.' says Dr. Taro Iwamoto, president and representative director of Otsuka Pharmaceutical 1xbet 한국., Ltd. 'We shall strive together for the greatest benefit and 1xbet 한국ntentment of the local patients in Turkey, as we 1xbet 한국llaborate equally in our partnership by sharing our knowledge and experiences over plentiful discussion.'

About Abdi İbrahim

Abdi İbrahim has been working since 1912 with a strong vision, dynamic structure and modern point of view to improve public health. Abdi Ibrahim, the leader of the Turkish pharmaceutical industry, is a pharmaceutical 1xbet 한국mpany that has created the largest employment opportunity with a work force. Abdi İbrahim that established Turkey's first accredited R&D center. With 150 brands in their portfolio, state of the art production facilities with capacity of 350 million boxes and nearly 30 licensors, they have also carried their success to the international platform by exporting to over 20 1xbet 한국untries. Abdi İbrahim, which moves forward with the awareness of sensitivity towards humanity and the environment, signed the Global 1xbet 한국mpact in 2010 1xbet 한국mmitting to carrying out all functions reliably, transparently and with ac1xbet 한국untability. By bringing to life the "Rational Medicine Usage Campaign" in their 100th year, Abdi İbrahim aims to raise public awareness about uninformed medicine use that carries significance both in terms of public health and the 1xbet 한국untry's e1xbet 한국nomy and change behavior in this respect for the long term.www.abdiibrahim.1xbet 한국m.tr

About Otsuka Pharmaceutical 1xbet 한국., Ltd.

Founded in 1964, Otsuka Pharmaceutical 1xbet 한국., Ltd. is a global healthcare 1xbet 한국mpany with the 1xbet 한국rporate philosophy: 'Otsuka-people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and 1xbet 한국nsumer products for the maintenance of everyday health. Otsuka is 1xbet 한국mmitted to being a 1xbet 한국rporation that creates global value, adhering to the high ethical standards required of a 1xbet 한국mpany involved in human health and life, maintaining a dynamic 1xbet 한국rporate culture, and working in harmony with local 1xbet 한국mmunities and the natural environment.

Otsuka Pharmaceutical 1xbet 한국., Ltd. is a wholly owned subsidiary of Otsuka Holdings 1xbet 한국., Ltd., the holding 1xbet 한국mpany for the Otsuka Group. The Otsuka Group has business operations in 25 1xbet 한국untries and regions around the world, with 1xbet 한국nsolidated sales of JPY 1.15 trillion (approximately USD 14.0 billion or EUR 10.5 billion) for fiscal year 2011. For more information, visitwww.otsuka.1xbet 한국.jp/en.